ZS Pharma (ZSPH) Acquired

Late-stage biotech developing a treatment for excess potassium (hyperkalemia).

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $89.98 0.00 (0.0%)
First Day Return 57.7%
Return from IPO 399.9%
 
ZS Pharma IPO News more
  • .
IPO Data
IPO File Date 05/15/2014
Offer Price $18.00
Price Range n/a
Offer Shares (mm) 5.9
Deal Size ($mm) 107
 
IPO Data
IPO Date 06/17/2014
Offer Price $18.00
Price Range n/a
Offer Shares (mm) 5.9
Deal Size ($mm) $107
 
Underwriters
more
Business Overview
Late-stage biotech developing a treatment for excess potassium (hyperkalemia).
Late-stage biotech developing a treatment for excess potassium (hyperkalemia).
more
Company Data
Headquarters Coppell, TX
Founded 2008
Employees 41
Website www.zspharma.com
 

Performance vs. IPO Index (IPOUSA)